Metabolic and functional consequences of cytosolic 5′ -nucleotidase-IA overexpression in neonatal rat cardiomyocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 3 54-3, 2003, Pages

  Sala Newby, Graciela B ^a   Freeman, Nicola V E ^a   Curto, Maria A ^a   Newby, Andrew C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

ATP metabolism; Catecholamines; Chronotropic effect

Indexed keywords

5' NUCLEOTIDASE; 5' NUCLEOTIDASE IA; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR BLOCKING AGENT; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; DIPYRIDAMOLE; ISOPRENALINE; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CATALYSIS; CELL METABOLISM; CHRONOTROPISM; ENERGY METABOLISM; ENERGY RESOURCE; ENZYME MECHANISM; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HYPOXIA; MOLECULAR CLONING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0041859203     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00053.2003     Document Type: Article

References (39)

1. Allegrini S, Scaloni A, Ferrara L, Pesi R, Pinna P, Sgarrella F, Camici M, Eriksson S, and Tozzi MG. Bovine cytosolic 5′-nucleotidase acts through the formation of an aspartate 52-phosphoenzyme intermediate. J Biol Chem 276: 33526-33532, 2001.
2. Berne RM. Regulation of coronary blood flow. Physiol Rev 44: 1-29, 1964.
3. Borst MM and Schrader J. Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine. Circ Res 68: 797-806, 1991.
4. Bukoski RD and Sparks HV. Adenosine production and release by adult rat cardiocytes. J Mol Cell Cardiol 18: 595-605, 1986.
5. De Jong JW and Kalkman C. Myocardial adenosine kinase: activity and localization determined with rapid radiometric assay. Biochim Biophys Acta 320: 388-396, 1973.
6. Deussen A, Möser G, and Schrader J. Contribution of coronary endothelial cells to cardiac adenosine production. Pflügers Arch 406: 608-614, 1986.
7. Deussen A, Stappert M, Schafer S, and Kelm M. Quantification of extracellular and intracellular adenosine production: understanding the transmembranous concentration gradient. Circulation 99: 2041-2047, 1999.
8. DeWitt DF, Wangler RD, Thompson CI, and Sparks HV. Phasic release of adenosine during steady state metabolic stimulation in the isolated guinea pig heart. Circ Res 53: 636-643, 1983.
9. Dobson JG and Schrader J. Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart. J Mol Cell Cardiol 16: 813-822, 1984.
10. Garvey EP, Lowen GT, and Almond MR. Nucleotide and nucleoside analogues as inhibitors of cytosolic 5′-nucleotidase I from heart. Biochemistry 37: 9043-9051, 1998.
11. Garvey EP and Prus KL. A specific inhibitor of heart cytosolic 5′-nucleotidase I attenuates hydrolysis of adenosine 5′ -monophosphate in primary rat myocytes. Arch Biochem Biophys 364: 235-240, 1999
12. Gulick T, Pieper S, Murphy M, Lange L, and Schreiner G. A new method for assessment of cultured cardiac myocyte contractility detects immune factor-mediated inhibition of beta-adrenergic responses. Circulation 84: 313-321, 1991.
13. Headrick JP, Matherne GP, and Berne RM. Myocardial adenosine formation during hypoxia: effects of ecto-5′-nucleotidase inhibition. J Mol Cell Cardiol 24: 295-303, 1992.
14. Hunsucker SA, Spychala J, and Mitchell BS. Human cytosolic nucleotidase-I: characterization and role in nucleoside analog resistance. J Biol Chem 276: 10498-10504, 2001.
15. Imai S, Chin WP, Jin H, and Nakazawa M. Production of AMP and adenosine in the interstitial fluid compartment of the isolated perfused normoxic guinea pig heart. Pflügers Arch 414: 443-449, 1989.
16. Jenkins JR and Belardinelli L. Atrioventricular nodal accommodation in isolated guinea pig hearts: physiological significance and role of adenosine. Circ Res 63: 97-116, 1988.
17. Jennings LL, Cass CE, Tritzel MWL, Yao SYM, Young JD, Griffiths M, and Baldwin SA. Adenosine transport: recent advances in the molecular biology of nucleoside transporter proteins. Drug Dev Res 45: 277-287, 1998.
18. 3H]-noradrenaline from the rat isolated heart: lack of relationship to prostaglandins. Br J Pharrnacol 68: 551-561, 1980.
19. Lorbar M, Fenton RA, and Dobson JG. ATP as a source of interstitial adenosine in the rat heart. Can J Physiol Pharmacol 77: 579-588, 1999.
20. Mahnke-Zizelman DK, D'Cunha J, Wojnar JM, Brogley MA, and Sabina RL. Regulation of rat AMP deaminase 3 (isoform C) by development and skeletal muscle fibre type. Biochem J 326: 521-529, 1997.
21. Meghji P, Holmquist CA, and Newby AC. Adenosine formation and release from neonatal-rat heart cells in culture. Biochem J 229: 799-805, 1985.
22. Nakano A, Cohen MV, and Downey JM. Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol Ther 86: 263-275, 2000.
23. Newby AC. Adenosine and the concept of "retaliatory metabolites." Trends Biochem Sci 9: 42-44, 1984.
24. Newby AC. The interaction of inhibitors with adenosine metabolising enzymes in intact isolated cells. Biochem Pharmacol 30: 2611-2615, 1981.
25. Obata T and Yamanaka Y. Tyramine produces interstitial adenosine-mediated activation of ecto-5′-nucleotidase in rat heart in vivo. Eur J Pharmacol 374: 25-31, 1999.
26. Oka J, Matsumoto A, Husokawa Y, and Inoue S. Molecular cloning of human cytosolic purine 5′-nucleotidase. Biochem Biophys Res Commun 205: 917-922, 1994.
27. Rundell KW, Tullson PC, and Terjung RL. Altered kinetics of AMP deaminase by myosin binding. Am J Physiol Cell Physiol 263: C294-C299, 1992.
28. Sala-Newby GB, Freeman NVE, Skladanowski AC, and Newby AC. Distinct roles for recombinant cytosolic 5′-nucleotidase-I and -II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines. J Biol Chem 275: 11666-11671, 2000.
29. Sala-Newby GB and Newby AC. Cloning of a mouse cytosolic 5′-nucleotidase-I identifies a new gene related to human autoimmune infertility-related protein. Biochim Biophys Acta 1521: 12-18, 2001.
30. Sala-Newby GB, Skladanowski AC, and Newby AC. The mechanism of adenosine formation in cells: cloning of cytosolic 5′-nucleotidase I. J Biol Chem 274: 17789-17793, 1999.
31. Schrader J. Adenosine: a homeostatic metabolite in cardiac energy metabolism. Circulation 81: 389-391, 1990.
32. Schrader J, Baumann G, and Gerlach E. Adenosine as inhibitor of myocardial effects of catecholamines. Pflügers Arch 372: 29-35, 1977.
33. Schutz W, Schrader J, and Gerlach E. Different sites of adenosine formation in the heart. Am J Physiol Heart Circ Physiol 240: H963-H970, 1981.
34. Shryock JC and Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79: 2-10, 1997.
35. Skladanowski AC and Newby AC. Partial purification and properties of an AMP-specific soluble 5′-nucleotidase from pigeon heart. Biochem J 268: 117-122, 1990.
36. Skladanowski AC, Smolenski RT, Tavernier M, de Jong JW, Yacoub MH, and Seymour AML. Soluble forms of 5′-nucleotidase in rat and human heart. Am J Physiol Heart Circ Physiol 270: H1493-H1500, 1996.
37. Wilkinson GWG and Akrigg A. Constitutive expression from the CMV major IE promotor in a defective adenovirus vector. Nucleic Acids Res 20: 2233-2239, 1992.
38. Worku Y and Newby AC. The mechanism of adenosine production in rat polymorphonyclear leucocytes. Biochem J 214: 325-330, 1983.
39. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362: 299-309, 2000.